CM Life Sciences, Inc. Unit
CMLFU
CMLFU was delisted on the 22nd of July, 2021.
42 hedge funds and large institutions have $233M invested in CM Life Sciences, Inc. Unit in 2020 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 6 increasing their positions, 15 reducing their positions, and 25 closing their positions.
28% less funds holding
Funds holding: 58 → 42 (-16)
41% less capital invested
Capital invested by funds: $393M → $233M (-$160M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
60% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 25
60% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$2.48M |
| 2 |
GS
Gagnon Securities
New York
|
+$1.84M |
| 3 |
GA
Gagnon Advisors
New York
|
+$1.43M |
| 4 |
JG
Jefferies Group
New York
|
+$674K |
| 5 |
BCM
Bluefin Capital Management
New York
|
+$500K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LA
Linden Advisors
New York
|
-$22M |
| 2 |
WMSA
Weiss Multi-Strategy Advisers
New York
|
-$21.9M |
| 3 |
Millennium Management
New York
|
-$21.4M |
| 4 |
Blackstone Inc
New York
|
-$16.5M |
| 5 |
TCIM
TOMS Capital Investment Management
New York
|
-$10.8M |
CMLFU Hedge Fund Activity: Q4 2020 in Review
42 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in CM Life Sciences, Inc. Unit (CMLFU) for Q4 2020, worth a combined $233M — down 41% from $393M a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of CMLFU and 10 opened new positions — a net loss of 15 holders — while 15 trimmed existing stakes and 6 added.
The largest buyer was Goldman Sachs, opening a new position worth an estimated $2.48M. The largest seller was Linden Advisors, exiting entirely with an estimated $22M sold.
- 42 institutional investors held CM Life Sciences, Inc. Unit (CMLFU) as of Q4 2020, down from 58 in Q3 2020.
- Funds reported $233M of CM Life Sciences, Inc. Unit stock for Q4 2020, down 41% quarter-over-quarter.
- 10 funds opened new CM Life Sciences, Inc. Unit positions in Q4 2020 and 25 closed out, a net change of -15 holders.
- The largest CM Life Sciences, Inc. Unit buyer in Q4 2020 was Goldman Sachs, an estimated $2.48M added.
- The largest CM Life Sciences, Inc. Unit seller in Q4 2020 was Linden Advisors, an estimated $22M sold.
Based on aggregated 13F filings for Q4 2020.